News | bioMérieux

bioMérieux increases its holding in Hybiome from 54% to 67%

06 June, 2019

Baxter and bioMérieux announce collaboration to improve identification and treatment of acute kidney injury

19 March, 2019

“Global-PPS”, a survey of antibiotic use and bacterial resistance in hospitals worldwide, tops the 200,000 patients

19 March, 2019

bioMérieux launches the BIOFIRE^® FILMARRAY^® Pneumonia Panels with FDA clearance and CE Marking

13 November, 2018

bioMérieux acquires a majority stake in Hybiome and strengthens its presence both in China and in the immunoassay market

09 November, 2018

bioMérieux – First-Half 2018 Results

05 September, 2018

bioMérieux – Second-Quarter 2018 Business Review

18 July, 2018

bioMérieux launches ENDOZYME^® II GO, an innovative test for the detection of endotoxins in pharmaceutical microbiology control

31 May, 2018

NEPHROCHECK Biomarkers TIMP-2 and IGFBP7 Included in Groundbreaking Consensus Statement of Best Practices to Enhance Recovery after Heart Surgery

02 May, 2018

bioMérieux and the University of Antwerp award scholarships to three healthcare professionals for their commitment to improve antibiotic use in order to combat antimicrobial resistance

23 April, 2018

Pioneering Diagnostics